Shares outstanding increased 5.6%
Shares outstanding changed +5.6% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +5.6% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Operating cash flow changed -17.1% from the comparable as-filed period.
Research & development changed +25.7% from the comparable as-filed period.
Operating income changed -12.4% from the comparable as-filed period.
Stock-based compensation changed -23.2% from the comparable as-filed period.
Net income changed -15.4% from the comparable as-filed period.
Current liabilities changed -15.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed -14.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed -14.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed -14.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -6.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed +19 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -4.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed +9.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +11.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cash & equivalents changed -22.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.